Mallinckrodt PLC
Change company Symbol lookup
Select an option...
MNKKQ Mallinckrodt PLC
MRAM Everspin Technologies Inc
LULU Lululemon Athletica Inc
SSYS Stratasys Ltd
ASTE Astec Industries Inc
NHTC Natural Health Trends Corp
DB Deutsche Bank AG
XPER Xperi Holding Corp
TT Trane Technologies PLC
UAA Under Armour Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Based in Ireland
Company profile

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

The symbol you entered, MNK, changed to MNKKQ.

Closing Price
$0.25
Day's Change
-0.0124 (-4.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2648
Day's Low
0.25
Volume
(Light)
Volume:
209,620

10-day average volume:
282,683
209,620

Company Profile

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
0.01x
Price/Book (MRQ)
0.03x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

MNKKQ is in a share class of common stock
Float
83.7M
Shares Outstanding
84.7M
Institutions Holding Shares
53
4.50%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Angus Charles Russell
  • Mark C. TrudeauPres.
  • Bryan M. ReasonsCFO
  • Ian J. Watkins
  • Steven RomanoExec.VP

Address

Insider Trading

During the most recent quarter, 517K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.